Aptose Biosciences
APTO
#10568
Rank
C$6.08 M
Marketcap
C$2.38
Share price
0.00%
Change (1 day)
-43.81%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -C$28.98 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$35.18 Million, an increase over its 2023 earnings that were of -C$73.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$28.98 Million-17.63%
2024 -C$35.18 Million-51.82%
2023 -C$73.02 Million22.9%
2022 -C$59.42 Million-34.91%
2021 -C$91.28 Million17.36%
2020 -C$77.78 Million107.65%
2019 -C$37.46 Million-7.73%
2018 -C$40.6 Million160.68%
2017 -C$15.58 Million-20.27%
2016 -C$19.54 Million28.71%
2015 -C$15.18 Million
2013 -C$8.61 Million
2010 -C$7.33 Million-8.31%
2009 -C$7.99 Million
2006 -C$14.82 Million-156.93%
2005 C$26.02 M-185.16%
2004 -C$30.56 Million458.58%
2003 -C$5.47 Million-63.66%
2002 -C$15.06 Million-8.04%
2001 -C$16.37 Million16.73%
2000 -C$14.03 Million294.99%
1999 -C$3.55 Million-6.51%
1998 -C$3.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-C$87.56 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-C$94.16 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-C$47.45 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA